BAYER AG To Go Ex-Dividend On April 29th, 2024 With 0.12138 USD Dividend Per Share
April 26th - $BAYER AG(BAYZF.US)$ is trading ex-dividend on April 29th, 2024. Shareholders of record on April 30th, 2024 will receive 0.12138 USD dividend per share on May 2nd, 2024. The ex-divide
moomoo NewsApr 25 21:00 ET
Autoinjectors Market Size Is Set to Grow by USD 134.01 Billion From 2023-2027, AbbVie Inc., Amgen Inc. and Bayer AG, and More to Emerge as Some of the Key Vendors, Technavio
The global autoinjectors market size is estimated to grow by USD 134014.58 million from 2023 to 2027, according to Technavio. The market is estimated ...
PR NewswireApr 22 18:15 ET
United States Pet Medication Market Insights Report 2024-2029 Featuring Prominent Vendors - Boehringer Ingelheim, Ceva, Elanco Animal Health, Merck, Zoetis, Bayer AG, and Novartis - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "U.S. Pet Medication Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.The U.S. Pet Medication Market was valued at USD 13.21
BusinesswireApr 17 07:11 ET
Non-Hodgkin Lymphoma Therapeutics Market Size Is Set to Grow by USD 5.42 Billion From 2023-2027, AstraZeneca Plc, Baxter International Inc. and Bayer AG, and More to Emerge as Some of the Key Vendors, Technavio
The global non-hodgkin lymphoma therapeutics market size is estimated to grow by USD 5427.51 mn from 2023 to 2027, according to Technavio. The market ...
PR NewswireApr 16 17:25 ET
Bayer Dethroned as Germany's Top Drugmaker
Seeking AlphaApr 16 12:23 ET
Bayer's Consumer-Healthcare Unit Remains Attractive Acquisition Target -- Market Talk
1401 GMT - Bayer's consumer-healthcare unit remains an attractive asset and its size and geographic footprint make it a good acquisition target should the German company decide to put it up for sale a
WSJApr 15 10:01 ET
Bayer's Debt Reduction, Litigation and Drug Pipeline in Focus at 1Q Results -- Market Talk
1336 GMT - Bayer's debt-reduction efforts, litigation and progress on its drug pipeline will be at the top of investors' minds when the company reports first-quarter results next month, Barclays analy
WSJApr 15 09:39 ET
Ginkgo Bioworks Acquires AgBiome's Platform Assets
Seeking AlphaApr 11 07:45 ET
Bayer and Google Cloud to Accelerate Development of AI-powered Healthcare Applications for Radiologists
New Bayer innovation platform will help organizations build AI-powered apps that assist radiologists, reducing burnout and supporting more efficient diagnoses BERLIN, April 9, 2024 /PRNewswire/ -- C
PR NewswireApr 9 08:18 ET
European Losers of Higher Financing Costs - JPMorgan
Seeking AlphaApr 8 09:41 ET
Bayer to Appeal US Court Decision to Cut 60% Punitive Damages From Weedkiller Cancer Verdict
Bayer (BAYN.F) plans to appeal a US court decision to slash $1 billion from the punitive damages owed by its unit Monsanto for cancer claims linked to its Roundup weedkiller, saying that the law was n
MT NewswiresApr 8 00:08 ET
Bayer Roundup Cancer Jury Award Cut by Nearly Two-thirds to $550M
Seeking AlphaApr 5 16:43 ET
Dr. Reddy's Laboratories, Bayer Collaborate to Distribute Second Brand of Heart Failure Drug in India
Dr. Reddy's Laboratories (RDY) and Bayer said Friday that they have entered into a collaboration to market and distribute a second brand of Vericiguat in India.
MT NewswiresApr 5 12:00 ET
Bayer-Backed Drug Maker Boundless Bio Raises $100 Million in IPO
Boundless Bio Inc., a cancer therapeutics maker that counts Bayer AG among its largest investors, raised $100 million in a US initial public offering after pricing shares at the midpoint of a marketed range.
BNN BloombergMar 27 20:04 ET
Bayer Sees Healthy Prospects in Nation
Acknowledging opportunities brought by China's pursuit of new quality productive forces, life sciences company Bayer AG said it is bullish on China's innovative business environment, and will continue to enhance its investment in the country.
China DailyMar 26 21:27 ET
Bayer-backed Boundless Bio Sets Terms for $100M IPO
Seeking AlphaMar 21 12:53 ET
Interferons Market Size Is Set to Grow by USD 2.65 Bn From 2024-2028, 3SBio Inc., Bayer AG & Biogen Inc., and More to Emerge as Some of the Key Vendors- Technavio
The global interferons market size is estimated to grow by USD 2.65 bn from 2024 to 2028, according to Technavio. The market is estimated to grow at...
PR NewswireMar 19 14:22 ET
Bayer's Third Menopausal Relief Drug Trial Meets Primary Goal, German Conglomerate Seeks FDA Approval For Elinzanetant
Tuesday, Bayer AG (OTC:BAYRY) (OTC:BAYZF) announced topline results of the Phase 3 study OASIS 3 evaluating the efficacy and long-term safety of the investigational compound elinzanetant versus placeb
BenzingaMar 19 09:31 ET
Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing
REHOVOT, Israel, March 19, 2024 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company that develops microbiome-based, computational-driven bio-stimulant and bio-pesticide novel products an
PR NewswireMar 19 09:00 ET
Bayer to Seek Regulatory Approval for Menopause Drug After Third Trial Success
Seeking AlphaMar 19 06:19 ET
No Data
No Data